Safety study of an injection for high lipoprotein(a)
Part of Heart & circulation clinical trials.
This study tests a new injected medicine called SAL0195 in healthy people to see if it is safe and how it works. It is especially for those with high levels of lipoprotein(a), a type of fat linked to heart disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- Your body weight must be at least 50 kg (110 lbs) for men or 45 kg (99 lbs) for women, and your body mass index (BMI) must be between 19 and 28.
- If you are in the higher-dose group, you must have high levels of lipoprotein(a) — a type of fat in the blood that can increase heart risk — confirmed by a blood test.
- You must be generally healthy, with no major heart, liver, kidney, or bleeding problems, and no active infections like hepatitis B, hepatitis C, or HIV.
- You must not have taken any prescription drugs, over-the-counter medicines, supplements, or herbal products within 2 weeks before the study starts.
- You must agree to use effective birth control (no hormonal birth control) and avoid pregnancy for 6 months after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental oral medication, SAL0137, to see if it can lower Lp(a) levels, a type of fat in the blood linked to heart disease. It may help people who have high Lp(a) and are at increased risk for heart attacks or strokes.
This study tests an investigational medicine given by injection to lower Lp(a), a type of fat linked to heart disease. It may help people with high Lp(a) who already have heart problems or are at increased risk.
This study tests a new medication called SAL0167, which may help lower cholesterol, in healthy volunteers. It is a first-in-human study, meaning it looks at safety and how your body handles the drug, so it may not directly benefit your health but helps in developing a potential treatment for high cholesterol.
This trial tests a new medicine called SRSD216 for people with high levels of lipoprotein (a), a type of fat in the blood that can increase heart disease risk. The study aims to see if the drug is safe and effective at lowering these levels.
This study tests an oral medication called HRS-5346 to see if it can lower a type of fat in the blood called lipoprotein(a), which is linked to heart disease. If you have high Lp(a) and are at risk for heart problems, this trial may help reduce that risk.
This trial tests a new drug called AZD4954 for safety. It includes healthy volunteers and people with high Lp(a) or dyslipidemia. The goal is to see if the drug is safe and how the body processes it.
Hear when a new Elevated Lipoprotein(a) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.